Sienna Biopharmaceuticals is a development stage company focused on the discovery, clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs. Sienna Biopharmaceuticals' management comprises executives with extensive experience and demonstrated success in taking new scientific ideas from discovery to commercialization, including many of the most successful global brands in aesthetics and medical dermatology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/29/16 | $34,000,000 | Series A |
Altitude Life Science Ventures ARCH Venture Partners Partner Fund Management Venvest Capital | undisclosed |
| 07/13/16 | $12,000,000 | Series A-2 |
ARCH Venture Partners Partner Fund Management Two River | undisclosed |
| 04/25/17 | $40,000,000 | Series B |
Altitude Life Science Ventures ARCH Venture Partners  Dr. David Pyott Fidelity Management & Research Company Partner Fund Management Venvest Capital | undisclosed |
